298380 — ABL Bio Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapMomentum Trap

Annual cashflow statement for ABL Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-43,558	3,209	-2,647	-55,529	-37,877
Depreciation
Amortisation
Non-Cash Items	8.95	7,275	7,474	2,038	2,543
Unusual Items
Other Non-Cash Items
Changes in Working Capital	785	59,323	-35,779	-18,322	-9,368
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-40,605	72,132	-28,362	-69,403	-41,253
Capital Expenditures	-1,266	-3,637	-5,844	-9,058	-20,671
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	21,487	-67,613	35,728	-38,116	82,784
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	20,221	-71,250	29,884	-47,174	62,113
Financing Cash Flow Items	-12.4	-11.7	-1,981	-7.39	-50.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	284	4,649	1,437	144,572	32,519
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-19,070	3,547	2,929	28,225	55,693